(Reuters Health) – If head and facial pain seem stronger and scarier than pain elsewhere, it’s because a special pathway in the brain is heightening our emotions from pain at those sites, according to studies in mice.
BRUSSELS (Reuters) – It may be a cross between the Eurovision Song Contest, a papal conclave and a social club raffle but a ballot among EU ministers on Monday could hurt Europe’s pharmaceutical industry and the health of millions.
SEOUL (Reuters) – Parasitic worms found in a North Korean soldier, critically injured during a desperate defection, highlight nutrition and hygiene problems that experts say have plagued the isolated country for decades.
Leo Tolstoy’s “War and Peace” is one of literature’s greatest hits. It also contains more than half a million words. I’ll get to it eventually, possibly not before I retire.
There’s no magic pill that will cure you of your cravings. But there is something that may help the effort, and it’s all-natural.
(Reuters) – The Trump administration on Thursday proposed changes to Medicare drug plans including limits on opioid prescriptions and rules aimed at reducing drug costs for seniors, such as requiring health insurers to pass on discounts to consumers.
(Reuters) – A California jury on Thursday ruled in favor of Johnson & Johnson in a lawsuit by a woman who said she developed the cancer mesothelioma after being exposed to asbestos in the company’s talc-based products including J&J’s Baby Powder.
Each fall, as leaves turn golden and the crisp autumn air carries the scent of pine, Catherine Franssen waits for her husband to bring home the latest pumpkin spice-flavored concoction he has discovered at the grocery store.
A man may soon be forever free of the previously incurable disease he was born with 44 years ago. On Monday, in a medical first, Brian Madeux received an experimental in-body gene-editing treatment intended to cure him of Mucopolysaccharidoses II, known as MPS II or Hunter syndrome, a rare disorder that causes progressive damage to the body’s cells.
CHICAGO (Reuters) – Monsanto Co and U.S. farm groups sued California on Wednesday to stop the state from requiring cancer warnings on products containing the widely used weed killer glyphosate, which the company sells to farmers to apply to its genetically engineered crops.